Skip to content

A trial of SPEN maintaining the stability of enterobacteria and reducing the translocation of enterobacteria in critical ill patients

A randomized, multicenter and prospective trial of SPEN maintaining the stability of enterobacteria and reducing the translocation of enterobacteria in critical ill patients

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029048
Enrollment
Unknown
Registered
2020-01-12
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal dysfunction

Interventions

Experimental group:Enteral nutrition with short-peptide formulation
Control group:Enteral nutrition with total protein formulation

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. Organ failure needs intensive treatment and has nutritional risk; 3. A valid enteral nutrition tube has been established; 4. Digestive juice (gastric juice, bile, pancreatic juice) can be effectively used directly or indirectly; 5. No intestinal flora disturbance; 6. No diarrhea.

Exclusion criteria

Exclusion criteria: 1. Urgent treatment is needed for perforation, hemorrhage and intestinal obstruction of abdominal cavity organs; 2. Intestinal ischemia or enteroparalysis; 3. Short bowel syndrome; 4. Bleeding and shock have not been corrected; 5. Oral diet is available; 6. History diseases of inflammatory bowel disease, chronic pancreatitis and irritable bowel syndrome; 7. Pregnancy; 8. Absent of informed consent from patient or representative.

Design outcomes

Primary

MeasureTime frame
The incidence rate of enterogenous infection;

Secondary

MeasureTime frame
intestinal flora disturbance;Bacterial enteritis or suspected bacterial enteritis;Feeding intolerance;New set of organ failure;The length of ICU stay;The length of hospital stay;

Countries

China

Contacts

Public ContactJiang Ronglin

The First Affiliated Hospital of Zhejiang Chinese Medical University

jiangronglin@126.com+86 13958095268

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026